Recent Finacing
Recent Raise
HebeCell develops off-the-shelf CAR‑NK therapeutics via 3D pluripotent stem cell platform, creating PSC-CAR cell banks for cancer, viral and autoimmune uses, operating labs in Natick and partnering with Jacobio.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at HebeCell.
